KÜmmel S - Search Results

1

Neo-adjuvant and/or Adjuvant Subcutaneous Trastuzumab (Herceptin^®) in Patients With Early HER2-positive Breast Cancer: Real World Data from a German Observational Study - (NIS HerSCin).

Schmidt M, KÜmmel S, Ruf-Doerdelmann A, Distelrath A, Wacker J, Schmatloch S, Busch-Liles S, LÜdtke-Heckenkamp K. Schmidt M, et al. Among authors: kummel s. Anticancer Res. 2021 Jan;41(1):485-496. doi: 10.21873/anticanres.14799. Anticancer Res. 2021. PMID: 33419847

2

Chemotherapy treatment options for elderly women with breast cancer.

Kümmel S, Elling D, Jeschke S, Schmid P, Thomas A. Kümmel S, et al. Anticancer Res. 2006 Mar-Apr;26(2C):1673-6. Anticancer Res. 2006. PMID: 16617560 Free article. Review.

3

Options and limits of surgery after pre-operative chemotherapy in breast cancer.

Thomas A, Ohlinger R, Hauschild M, Mustea A, Blohmer JU, Kümmel S. Thomas A, et al. Among authors: kummel s. Anticancer Res. 2006 Mar-Apr;26(2C):1677-82. Anticancer Res. 2006. PMID: 16617561 Free article. Review.

4

Postoperative therapy modalities for cervical carcinoma.

Kümmel S, Thomas A, Jeschke S, Hauschild M, Sehouli J, Lichtenegger W, Blohmer JU. Kümmel S, et al. Anticancer Res. 2006 Mar-Apr;26(2C):1707-13. Anticancer Res. 2006. PMID: 16617565 Free article. Review.

5

Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes.

Kümmel S, Eggemann H, Lüftner D, Thomas A, Jeschke S, Zerfel N, Heilmann V, Emons G, Zeiser T, Ulm K, Kobl M, Korlach S, Schmid P, Sehouli J, Elling D, Blohmer JU. Kümmel S, et al. Anticancer Res. 2006 Mar-Apr;26(2C):1719-26. Anticancer Res. 2006. PMID: 16617567 Free article. Clinical Trial.

6

The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.

Fuchs I, Vorsteher N, Bühler H, Evers K, Sehouli J, Schaller G, Kümmel S. Fuchs I, et al. Among authors: kummel s. Anticancer Res. 2007 Mar-Apr;27(2):959-63. Anticancer Res. 2007. PMID: 17465227 Free article.

7

High-frequency breast ultrasound for the detection of microcalcifications and associated masses in BI-RADS 4a patients.

Stöblen F, Landt S, Ishaq R, Stelkens-Gebhardt R, Rezai M, Skaane P, Blohmer JU, Sehouli J, Kümmel S. Stöblen F, et al. Among authors: kummel s. Anticancer Res. 2011 Aug;31(8):2575-81. Anticancer Res. 2011. PMID: 21778307

8

Prognostic significance of angiogenic factors in uterine cervical cancer.

Landt S, Wehling M, Heidecke H, Jeschke S, Korlach S, Stöblen F, Schmid P, Blohmer JU, Lichtenegger W, Sehouli J, Kümmel S. Landt S, et al. Among authors: kummel s. Anticancer Res. 2011 Aug;31(8):2589-95. Anticancer Res. 2011. PMID: 21778309

9

Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes.

Eggeman H, Stöblen F, Thill M, Korlach S, Schmid P, Lüftner D, Elling D, Taran FA, Kümmel S, Landt S. Eggeman H, et al. Among authors: kummel s. Anticancer Res. 2011 Aug;31(8):2617-22. Anticancer Res. 2011. PMID: 21778313

10

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial.

Untch M, Loibl S, Bischoff J, Eidtmann H, Kaufmann M, Blohmer JU, Hilfrich J, Strumberg D, Fasching PA, Kreienberg R, Tesch H, Hanusch C, Gerber B, Rezai M, Jackisch C, Huober J, Kühn T, Nekljudova V, von Minckwitz G; German Breast Group (GBG); Arbeitsgemeinschaft Gynäkologische Onkologie-Breast (AGO-B) Study Group. Untch M, et al. Lancet Oncol. 2012 Feb;13(2):135-44. doi: 10.1016/S1470-2045(11)70397-7. Epub 2012 Jan 17. Lancet Oncol. 2012. PMID: 22257523 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page